Trials / Recruiting
RecruitingNCT06686914
The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- West Virginia University · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The objectives/purpose of this study are to comprehensively investigate the effects of non-prescription CBD on driving performance, drowsiness, sedation, and cognitive function in a large sample of healthy adults aged 18-30 years, with additional characterization of effects by dose and by sex, using a rigorous RCT design which will naturally mitigate confounding factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabidiol (CBD) Oil 300mg | Cannabidiol (CBD) Oil 300mg, 1 dose |
| DRUG | Cannabidiol (CBD) Oil 150mg | Cannabidiol (CBD) Oil 150mg, 1 dose |
| DRUG | Placebo Oil | Placebo Oil, 1 dose |
Timeline
- Start date
- 2025-06-30
- Primary completion
- 2028-12-31
- Completion
- 2029-05-01
- First posted
- 2024-11-13
- Last updated
- 2025-10-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06686914. Inclusion in this directory is not an endorsement.